Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
Recruiting · NCT06956326 · Interventional (participants receive a specific treatment) · Lead sponsor: Lars Hvid
View the official record on ClinicalTrials.gov →Interventions studied
Intensive rehabUsual care
What this trial is about
The overall purpose of this project is to develop and test an infrastructure that can ensure early and specialized rehabilitation for individuals with multiple sclerosis (MS) on their path to recovery from a relapse. If this project proves successful, it can therefore help optimize clinical practice and provide a significant contribution to the treatment of relapsing-remitting sclerosis.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- admitted to the Danish MS Hospitals for an inpatient rehabilitation stay
- confirmed motor relapse (within the past 6 months) by a neurologist, with disability/ functional interference characterized by change in pyramidal, and/or cerebellar functional scores of 2 or higher
- completed steroid or other acute relapse treatment, if prescribed
- age over 18 years
Exclusion criteria
- more than 6 months since onset of motor relapse
- medical conditions or substantial cognitive impairments that hinder participation in the study (e.g. inability to perform or understand the intensive rehabilitation)
- pregnancy
Where it is running
2 locations listed.
- The Danish MS Hospitals - Haslev, Denmark
- The Danish MS Hospitals - Ry, Denmark